Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1260574.RAFkPT2xQRa7wMLSZOn7yr5TGs_YXSeFYua_v9UPrJOlI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1260574.RAFkPT2xQRa7wMLSZOn7yr5TGs_YXSeFYua_v9UPrJOlI130_assertion type Assertion NP1260574.RAFkPT2xQRa7wMLSZOn7yr5TGs_YXSeFYua_v9UPrJOlI130_head.
- NP1260574.RAFkPT2xQRa7wMLSZOn7yr5TGs_YXSeFYua_v9UPrJOlI130_assertion description "[It was also shown by flow cytometry that, compared with the scramble-treated group (negative control), the proliferation index value of ECA-109 cells in the si-CDKN2B-AS1 treatment group was notably increased (25.7 vs. 51.7%) and the TERT protein level was increased by 67.25% after the cells were treated with si-CDKN2B-AS1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260574.RAFkPT2xQRa7wMLSZOn7yr5TGs_YXSeFYua_v9UPrJOlI130_provenance.
- NP1260574.RAFkPT2xQRa7wMLSZOn7yr5TGs_YXSeFYua_v9UPrJOlI130_assertion evidence source_evidence_literature NP1260574.RAFkPT2xQRa7wMLSZOn7yr5TGs_YXSeFYua_v9UPrJOlI130_provenance.
- NP1260574.RAFkPT2xQRa7wMLSZOn7yr5TGs_YXSeFYua_v9UPrJOlI130_assertion SIO_000772 25646744 NP1260574.RAFkPT2xQRa7wMLSZOn7yr5TGs_YXSeFYua_v9UPrJOlI130_provenance.
- NP1260574.RAFkPT2xQRa7wMLSZOn7yr5TGs_YXSeFYua_v9UPrJOlI130_assertion wasDerivedFrom befree-2016 NP1260574.RAFkPT2xQRa7wMLSZOn7yr5TGs_YXSeFYua_v9UPrJOlI130_provenance.
- NP1260574.RAFkPT2xQRa7wMLSZOn7yr5TGs_YXSeFYua_v9UPrJOlI130_assertion wasGeneratedBy ECO_0000203 NP1260574.RAFkPT2xQRa7wMLSZOn7yr5TGs_YXSeFYua_v9UPrJOlI130_provenance.